
Understanding Biologic Medications: How Stelara & Prolia Work
Learn how biologic medications like Stelara and Prolia treat chronic conditions by targeting specific parts of the immune system and bone cells.
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993

For visual reference only; actual product may vary
US Name:
Beovu
Alternative Names:
Beovu
Active Ingredients:
Brolucizumab
Brand Manufacturer:
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

For visual reference only; actual product may vary
Beovu (brolucizumab) is a prescription medication used to treat wet age-related macular degeneration (wet AMD) via intravitreal injection. It helps prevent vision loss by inhibiting the growth of abnormal blood vessels in the retina. This product requires cold shipping to maintain its integrity.
| Beovu Brand | 6mg 1 Pre-Filled Syringe |
-
|
Our price: $1,210.00 |
Beovu (brolucizumab) is an injectable prescription medicine used to treat neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME). It is designed to help patients maintain or improve their vision by targeting a key factor in these conditions. As a newer anti-VEGF treatment, Beovu offers a potent solution administered directly into the eye by a healthcare professional to ensure it acts exactly where it is needed.
Beovu works by inhibiting the function of vascular endothelial growth factor A (VEGF-A), a protein that stimulates the growth of abnormal and leaky blood vessels in the retina. In conditions like wet AMD, these blood vessels can cause fluid to leak, damaging the macula and leading to vision loss. By blocking VEGF-A, Beovu reduces this vessel growth and leakage, which can help to dry the retina, reduce swelling, and slow the progression of vision loss.
Beovu is for adult patients who have been diagnosed with wet age-related macular degeneration or diabetic macular edema. It is a suitable option for individuals who require treatment to prevent further vision decline and, in some cases, to improve sight. This medication may be prescribed to newly diagnosed patients or those who are switching from another anti-VEGF therapy, often with the potential for less frequent dosing compared to other treatments after an initial loading phase.
Beovu is administered by a qualified ophthalmologist as an intravitreal injection directly into the vitreous humor of the eye. The procedure is performed in a clinical setting under sterile conditions and the eye is numbed to minimize discomfort. Typically, treatment begins with a series of loading doses. Following the initial phase, the dosing interval can often be extended, depending on the patient’s response and disease activity, as determined by their doctor. Your ophthalmologist will create a specific treatment schedule tailored to your condition.
Common side effects of Beovu can include temporary blurred vision, eye redness, cataracts, eye pain, and floaters. These are often related to the injection procedure itself. However, more serious side effects are possible, such as significant intraocular inflammation, retinal vasculitis, or retinal vascular occlusion, which can lead to severe vision loss. It is critical to immediately report any significant changes in vision, severe eye pain, or increased sensitivity to light to your doctor. An extensive list of potential side effects is provided in the patient information leaflet.
IsraelPharm provides a reliable and cost-effective source for purchasing your prescribed Beovu treatment online. We are committed to patient safety and access, ensuring you receive authentic medication shipped directly to your door. Our service includes necessary cold-chain shipping to guarantee the integrity and effectiveness of your Beovu injection. With competitive pricing and a straightforward ordering process, IsraelPharm helps you manage your eye health affordably and conveniently, backed by our knowledgeable customer support team.
Common Side Effects:
Serious Side Effects:
Beovu is indicated for the treatment of:
A Beovu injection is given by a qualified ophthalmologist directly into your eye (intravitreal injection). Before the shot, your doctor will clean the eye to prevent infection and use anesthetic drops to numb it. The procedure is quick and performed in a clinical setting. You will receive specific aftercare instructions to ensure proper healing and minimize infection risk.
Treatment frequency for Beovu varies. Patients typically start with a few monthly "loading doses." After this initial period, your ophthalmologist will assess your eye's response. Depending on disease activity, your injections may be scheduled every 8 to 12 weeks. Your doctor will determine the best treatment interval for your specific condition to effectively manage your AMD or DME.
Missing a scheduled Beovu injection can disrupt your treatment plan and potentially allow the disease to progress, which could affect your vision. If you miss an appointment, contact your ophthalmologist's office as soon as possible to reschedule. Do not wait for your next regularly scheduled visit. Promptly getting back on track is key to managing your condition effectively.
Currently, there is no cure for wet AMD. Beovu is not a cure, but it is a highly effective treatment for managing the disease. It works to slow the progression of vision loss and, in many cases, can help improve or maintain existing vision. The goal of treatment is to control the abnormal blood vessel growth and leakage in the retina, preserving sight for as long as possible.
The most common side effects associated with Beovu are typically mild and related to the injection itself. These can include eye redness (from a small bleed on the surface), temporary blurred vision, eye pain, and seeing floaters. These symptoms usually resolve within a few days. If they persist or worsen, you should contact your eye doctor for advice.
Yes, while less common, serious risks are associated with Beovu. These include a severe eye infection (endophthalmitis), retinal detachment, and increased eye pressure. A specific risk for Beovu is intraocular inflammation, including retinal vasculitis and retinal vascular occlusion, which can cause sudden and severe vision loss. Report any severe pain or significant vision changes to your doctor immediately.
Patients may begin to notice an improvement in their vision or a stabilization of their condition within the first few weeks to months after starting Beovu treatment. The response varies for each individual. The initial series of loading doses is designed to quickly bring the retinal fluid under control, and your doctor will monitor your progress closely using imaging tests like OCT scans.
It is generally recommended that you do not drive yourself home after a Beovu injection. Your eye will be dilated, and your vision may be blurry or sensitive to light immediately following the procedure. It is safest to arrange for someone to drive you home. Your doctor will provide specific instructions on when it is safe for you to resume driving.
Most patients experience little to no pain during a Beovu injection. Your ophthalmologist will use powerful anesthetic (numbing) eye drops before the procedure. You might feel a brief moment of pressure, but sharp pain is uncommon. It is normal to have some mild soreness or a gritty feeling in the eye for a day or two afterward.
After your injection, your doctor will likely advise you to avoid strenuous activities for a few days to minimize the risk of complications. You should also avoid getting water or soap in the treated eye and refrain from rubbing it. Follow your doctor's specific aftercare instructions carefully to ensure the eye heals properly and to reduce the risk of infection.
Beovu must be kept refrigerated at a specific temperature (2°C to 8°C or 36°F to 46°F) in its original C. It must not be frozen. This is why IsraelPharm ships Beovu with a mandatory cold shipping service to ensure the medication remains stable and effective from our pharmacy to your door. Your doctor's office will handle the medication during your appointment.
Currently, there is no generic version of Beovu available. Brolucizumab is the active ingredient, but Beovu is a brand-name biologic drug protected by patents. It may be several years before a biosimilar or generic equivalent becomes available on the market. Therefore, you must purchase the brand-name product for this specific treatment.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Learn how biologic medications like Stelara and Prolia treat chronic conditions by targeting specific parts of the immune system and bone cells.

For so many women, their own health takes a back seat – not because they ignore it, but rather because life is loud. Work, family, caregiving, aging parents, hormones, sleep, stress. Life is like a

Despite years of research and real-world use, there is still no FDA-approved testosterone therapy designed specifically for women. Now, that gap is getting renewed attention. Discussion around testosterone therapy for women has shifted in recent


